Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reboxetine Plus Ritalin vs Dog-Assisted Therapy in PTSD
NCT07771530Phase 2Recruiting
- Sponsor
- University of Haifa
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 2 trial of reboxetine, methylphenidate hydrochloride extended-release chewable tablet in post-traumatic stress disorder (PTSD), sponsored by University of Haifa. Started Aug 2026; status: recruiting.
02
Drugs
reboxetinemethylphenidate hydrochloride extended-release chewable tablet
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07771530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07771530.